We are live on ! Find out more
ADILW

Adial Pharmaceuticals Warrant
ADILW

Delisted

ADILW was delisted on the 27th of July, 2023.

Back to rankings

2 hedge funds and large institutions have $9K invested in Adial Pharmaceuticals Warrant in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more capital invested

Capital invested by funds: $1K → $9K (+$8K)

100% more funds holding

Funds holding: 1 → 2 (+1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$7.29K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$8
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$8K +$7.29K +21,686 New
UBS Group
2
UBS Group
Switzerland
$1K -$8 -24 -0.6%

ADILW Hedge Fund Activity: Q4 2020 in Review

2 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals Warrant (ADILW) for Q4 2020, worth a combined $9K — up 800% from $1K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ADILW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $7.29K. The largest seller was UBS Group, cutting an estimated $8.

  • 2 institutional investors held Adial Pharmaceuticals Warrant (ADILW) as of Q4 2020, up from 1 in Q3 2020.
  • Funds reported $9K of Adial Pharmaceuticals Warrant stock for Q4 2020, up 800% quarter-over-quarter.
  • 1 fund opened new Adial Pharmaceuticals Warrant positions in Q4 2020 and 0 closed out, a net change of +1 holder.
  • The largest Adial Pharmaceuticals Warrant buyer in Q4 2020 was Susquehanna International Group, an estimated $7.29K added.
  • The largest Adial Pharmaceuticals Warrant seller in Q4 2020 was UBS Group, an estimated $8 sold.

Based on aggregated 13F filings for Q4 2020.